Accessible, safe and high-quality healthcare

Ensuring healthcare that is accessible, safe, and high-quality is a growing challenge in a rapidly changing world. 

LIST is tackling this by creating connected, secure, and data-driven healthcare systems, alongside innovative materials and sensors that enable personalized care at lower costs. We also develop high-resolution analytical technologies, including lab-on-a-chip systems, to support precision diagnostics, drug analysis, and medical innovation—helping to deliver better outcomes for patients and healthcare providers alike.

Our fields of action

We design sustainable, lightweight composites that are strong, safe, and recyclable for applications like prosthetics, exoskeletons, and protective equipment. We also create antimicrobial polymers for biocompatible implants and use 3D/4D printing to deliver customizable tissue engineering solutions.

We build secure, interoperable digital infrastructures that protect patient data while enabling personalized, AI-powered care. Using wearable and sensor data, we create digital twins, AI-assisted diagnostics, and tailored interventions for prevention and chronic disease management—delivering high-quality, accessible healthcare.

We design portable breath-analysis devices for real-time, non-invasive disease detection and personalized healthcare. We also develop next-generation lab-on-a-chip systems with nanoplasmonic biosensors and graphene-based platforms for protein sequencing, as well as high-throughput peptide microarray tools for drug discovery—paving the way for breakthroughs in precision medicine, biotechnology, and related sectors.

We pioneer lab-on-a-chip systems that combine microfluidics, electrochemistry, and innovative biosensors to deliver highly sensitive, miniaturized, and multiplexed solutions for healthcare, agriculture, and environmental monitoring. We are also developing graphene-based platforms for scalable protein sequencing and a novel peptide microarray drug discovery platform, enabling rapid, high-throughput molecular screening and breakthroughs in precision medicine and biotechnology.

We develop and refine analytical instruments and workflows that transform healthcare diagnostics and research. We enhance the npSCOPE platform with high-resolution imaging and mass spectrometry for detailed morphological and chemical insights, while optimizing and automating molecular imaging workflows to improve sensitivity and specificity in neuroscience, cancer research, dermatology, and toxicology. Our goal is to deliver, validate, and implement industry-ready prototypes for clinical research and pharmaceutical applications.

Our solutions

Through secure digital infrastructures, AI-driven diagnostics, and personalised health solutions, we are advancing accessible, safe, and high-quality healthcare.

Latest related news

Healthtech: Cybersecurity at the heart of tomorrow’s medicine

21.10.2025

View more
Invitrolize Secures Strategic Investment to Expand ALIsens® Deployment Across Europe and the US

14.05.2025

View more
LIST and MyelinZ are bringing multiple sclerosis monitoring home

16.12.2024

View more

Contacts

Feiza Benzaghou

Business developer

Email

How can we help you?

By content type (optional)